| Gemcitabine |
AC144449.1 |
Curated lncRNA |
pancreatic cancer |
|
| Gemcitabine |
AF086204 |
Curated lncRNA |
pancreatic cancer |
|
| Gemcitabine |
CFLP3 |
Curated lncRNA |
pancreatic cancer |
|
| Gemcitabine |
CR619813 |
Curated lncRNA |
pancreatic cancer |
|
| Gemcitabine |
CTC-338M12.5 |
Curated lncRNA |
pancreatic cancer |
|
| Gemcitabine |
DDX6P |
Curated lncRNA |
pancreatic cancer |
|
| Gemcitabine |
ENSG00000117242.7 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000118412.8 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000152487.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000170161.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000170846.11 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000172965.10 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000174171.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000175699.8 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000175701.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000177337.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000177757.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000177788.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000177822.3 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000177822.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000177993.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000178803.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000178803.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000178947.8 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000179406.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000179406.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000179743.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000179935.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000179935.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000180139.10 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000181800.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000182057.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000182165.13 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000182376.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000182404.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000182648.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000184274.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000185203.7 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000186019.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000186594.8 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000186594.8 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000189196.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000189223.9 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000196756.7 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000197308.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000198468.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000203280.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000203307.2 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000203325.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000203327.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000203356.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000203496.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000203499.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000203506.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000203645.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000203801.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000203808.6 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000203808.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000204044.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000204054.7 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000204055.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000204528.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000204792.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000204815.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000204860.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000205037.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000205037.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000205500.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000205885.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000212163.2 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000212552.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000212694.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000212930.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000213793.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000213863.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000213981.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000214049.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000214347.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000214407.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000214407.3 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000214650.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000214770.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000214770.2 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000214803.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000214922.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000215039.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000215039.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000215068.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000215159.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000215256.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000215304.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000215394.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000215447.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000215863.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000216863.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000219665.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000219665.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000222041.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000223380.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000223387.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000223393.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000223477.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000223478.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000223485.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000223528.3 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000223598.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000223652.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000223660.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000223685.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000223685.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000223695.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000223745.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000223759.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000223759.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000223768.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000223779.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000223804.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000223806.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000223821.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000223839.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000223839.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000223842.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000223884.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000223901.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000223935.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000224000.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000224020.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000224023.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000224043.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000224216.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000224216.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000224216.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000224271.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000224292.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000224358.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000224376.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000224394.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000224481.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000224533.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000224549.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000224574.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000224635.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000224660.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000224671.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000224700.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000224761.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000224764.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000224764.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000224804.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000224810.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000224818.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000224843.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000224846.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000224855.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000224871.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000224875.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000224884.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000224932.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000224945.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000224950.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000224965.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000224973.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000224992.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000224995.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000225057.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000225057.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000225076.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000225092.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000225112.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000225113.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000225138.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000225140.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000225172.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000225187.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000225205.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000225205.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000225302.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000225331.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000225353.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000225353.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000225393.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000225439.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000225439.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000225442.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000225489.2 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000225511.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000225511.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000225572.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000225619.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000225667.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000225676.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000225684.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000225703.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000225760.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000225767.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000225767.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000225791.2 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000225793.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000225836.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000225839.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000225880.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000225914.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000225929.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000225953.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000225953.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000225963.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000225969.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000225973.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000225975.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000226007.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000226047.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000226067.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000226067.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000226149.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000226167.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000226193.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000226251.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000226266.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000226266.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000226281.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000226334.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000226380.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000226533.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000226562.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000226637.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000226649.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000226792.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000226812.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000226824.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000226833.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000226862.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000226876.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000226890.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000226913.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000226920.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000226950.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000226965.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000227014.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000227017.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000227053.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000227070.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000227071.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000227082.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000227117.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000227136.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000227145.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000227188.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000227195.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000227245.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000227279.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000227285.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000227372.6 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000227392.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000227403.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000227407.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000227456.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000227477.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000227477.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000227482.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000227512.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000227517.2 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000227518.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000227527.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000227533.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000227543.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000227589.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000227591.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000227617.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000227627.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000227630.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000227676.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000227678.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000227695.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000227719.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000227733.4 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000227844.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000227848.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000227888.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000227925.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000227946.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000227953.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000227959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000227963.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000228022.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000228028.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000228043.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000228079.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000228084.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000228126.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000228133.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000228140.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000228140.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000228153.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000228261.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000228288.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000228288.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000228293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000228294.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000228322.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000228323.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000228323.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000228323.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000228340.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000228340.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000228350.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000228395.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000228412.2 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000228436.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000228437.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000228470.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000228486.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000228487.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000228526.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000228540.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000228554.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000228624.3 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000228677.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000228775.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000228775.3 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000228779.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000228786.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000228817.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000228838.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000228886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000228886.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000229036.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000229043.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000229111.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000229162.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000229214.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000229214.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000229404.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000229525.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000229563.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000229666.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000229702.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000229723.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000229776.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000229841.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000229841.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000229848.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000229867.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000229867.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000229891.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000229931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000229931.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000229952.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000229953.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000229955.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000229999.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000230021.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000230061.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000230061.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000230068.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000230074.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000230102.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000230133.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000230172.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000230184.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000230212.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000230423.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000230423.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000230423.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000230433.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000230438.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000230438.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000230454.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000230479.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000230487.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000230542.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000230550.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000230565.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000230612.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000230658.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000230658.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000230730.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000230736.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000230753.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000230812.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000230815.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000230850.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000230912.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000230914.2 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000230925.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000230937.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000230939.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000231025.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000231028.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000231050.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000231064.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000231185.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000231187.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000231196.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000231201.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000231226.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000231249.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000231290.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000231290.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000231329.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000231367.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000231393.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000231393.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000231422.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000231437.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000231481.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000231507.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000231512.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000231527.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000231527.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000231528.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000231595.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000231595.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000231607.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000231609.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000231611.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000231636.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000231646.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000231652.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000231711.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000231711.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000231721.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000231742.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000231770.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000231789.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000231842.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000231871.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000231877.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000231889.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000231890.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000231903.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000231908.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000231964.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000231977.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000232031.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000232085.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000232116.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000232117.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000232139.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000232229.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000232300.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000232324.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000232325.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000232352.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000232377.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000232388.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000232445.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000232453.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000232519.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000232533.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000232545.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000232564.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000232628.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000232638.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000232645.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000232648.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000232648.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000232656.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000232732.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000232732.5 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000232739.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000232807.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000232807.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000232811.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000232878.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000232907.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000232912.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000232935.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000232936.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000232956.4 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000232969.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000232986.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000233029.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000233030.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000233080.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000233101.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000233137.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000233144.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000233154.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000233178.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000233220.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000233220.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000233230.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000233244.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000233250.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000233251.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000233296.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000233303.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000233330.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000233334.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000233355.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000233368.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000233427.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000233483.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000233509.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000233521.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000233532.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000233593.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000233593.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000233621.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000233642.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000233654.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000233665.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000233693.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000233757.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000233757.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000233776.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000233799.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000233818.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000233825.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000233834.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000233862.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000233864.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000233901.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000233903.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000233912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000234019.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000234076.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000234084.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000234091.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000234141.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000234155.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000234183.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000234232.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000234232.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000234232.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000234380.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000234394.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000234428.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000234437.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000234535.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000234546.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000234571.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000234617.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000234626.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000234678.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000234684.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000234698.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000234705.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000234753.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000234880.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000234883.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000234892.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000234915.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000234921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000234943.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000234943.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000235033.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000235085.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000235096.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000235106.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000235159.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000235180.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000235246.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000235262.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000235298.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000235298.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000235381.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000235387.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000235398.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000235419.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000235427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000235475.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000235499.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000235590.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000235590.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000235643.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000235724.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000235726.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000235740.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000235740.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000235779.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000235785.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000235806.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000235823.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000235848.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000235872.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000235884.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000235904.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000235927.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000235999.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000235999.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000236064.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000236066.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000236091.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000236091.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000236098.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000236107.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000236140.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000236197.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000236199.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000236200.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000236209.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000236213.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000236308.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000236337.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000236358.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000236384.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000236404.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000236404.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000236426.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000236434.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000236434.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000236438.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000236449.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000236514.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000236519.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000236545.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000236581.4 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000236591.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000236601.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000236643.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000236658.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000236668.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000236671.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000236671.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000236850.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000236869.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000236896.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000236901.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000236901.3 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000236921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000236935.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000236936.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000236943.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000237021.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000237021.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000237027.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000237073.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000237298.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000237328.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000237328.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000237336.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000237423.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000237424.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000237436.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000237476.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000237481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000237489.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000237520.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000237523.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000237594.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000237595.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000237595.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000237596.2 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000237605.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000237605.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000237646.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000237646.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000237686.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000237689.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000237689.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000237781.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000237853.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000237899.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000237914.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000237927.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000237928.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000237934.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000237945.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000237976.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000237993.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000238018.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000238042.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000238045.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000238057.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000238121.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000238140.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000238160.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000238184.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000238273.3 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000238280.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000238287.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000238290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000239002.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000239377.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000239415.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000239445.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000239569.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000239653.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000239653.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000239674.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000239674.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000239677.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000239774.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000240057.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000240057.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000240143.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000240143.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000240211.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000240219.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000240449.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000240453.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000240549.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000240766.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000241219.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000241280.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000241280.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000241472.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000241520.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000241720.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000241732.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000241954.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000241985.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000242094.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000242375.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000242391.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000242396.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000242474.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000242522.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000242540.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000242759.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000242797.2 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000242828.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000243368.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000243533.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000243637.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000243701.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000243797.2 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000243810.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000243810.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000243849.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000243849.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000243849.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000243926.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000243944.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000243960.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000244124.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000244198.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000244198.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000244203.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000244332.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000244332.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000244332.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000244459.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000244479.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000244479.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000244738.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000244968.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000245060.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000245060.2 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000245112.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000245149.3 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000245248.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000245468.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000245532.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000245534.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000245552.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000245685.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000245812.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000246174.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000246250.2 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000246323.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000246528.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000246790.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000246859.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000247095.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000247516.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000247624.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000247675.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000247679.2 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000247774.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000247809.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000247853.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000247970.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000247970.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000247982.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000248019.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000248125.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000248132.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000248161.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000248175.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000248187.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000248309.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000248367.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000248367.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000248473.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000248476.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000248559.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000248663.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000248668.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000248714.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000248714.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000248758.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000248774.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000248846.2 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000248925.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000248925.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000248932.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000248996.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000249216.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000249252.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000249252.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000249293.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000249307.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000249310.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000249328.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000249345.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000249359.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000249364.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000249375.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000249395.2 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000249430.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000249487.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000249532.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000249550.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000249572.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000249602.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000249610.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000249635.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000249655.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000249669.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000249684.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000249700.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000249717.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000249734.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000249740.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000249786.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000249942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000250007.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000250056.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000250057.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000250073.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000250073.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000250075.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000250081.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000250116.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000250132.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000250155.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000250159.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000250222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000250234.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000250282.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000250286.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000250302.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000250410.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000250519.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000250541.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000250548.2 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000250608.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000250614.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000250635.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000250692.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000250765.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000250822.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000250910.3 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000250948.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000250988.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000250988.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000250999.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000251003.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000251003.3 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000251141.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000251143.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000251151.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000251161.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000251323.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000251330.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000251331.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000251350.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000251442.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000251497.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000251523.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000251536.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000251538.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000251556.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000251562.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000251562.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000251574.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000251580.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000253106.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000253112.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000253121.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000253172.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000253174.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000253174.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000253210.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000253222.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000253286.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000253298.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000253399.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000253420.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000253476.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000253476.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000253522.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000253526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000253582.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000253669.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000253701.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000253708.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000253736.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000253737.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000253796.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000253824.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000253825.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000253829.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000253837.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000253837.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000253842.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000253865.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000253865.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000253875.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000253875.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000253880.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000253893.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000253917.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000253948.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000253955.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000253961.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000253978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000253986.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000254006.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000254008.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000254028.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000254099.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000254101.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000254129.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000254142.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000254162.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000254162.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000254205.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000254231.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000254248.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000254275.2 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000254295.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000254343.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000254389.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000254418.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000254427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000254428.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000254433.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000254458.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000254480.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000254484.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000254510.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000254526.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000254602.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000254615.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000254639.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000254664.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000254671.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000254691.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000254739.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000254777.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000254821.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000254869.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000254869.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000254900.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000254910.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000254987.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000255002.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000255045.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000255052.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000255094.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000255129.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000255129.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000255164.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000255227.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000255236.2 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000255276.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000255308.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000255320.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000255343.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000255354.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000255366.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000255372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000255421.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000255449.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000255455.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000255471.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000255476.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000255495.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000255557.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000255650.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000255693.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000255741.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000255867.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000255970.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000255992.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000256001.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000256050.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000256124.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000256128.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000256195.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000256196.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000256199.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000256268.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000256325.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000256325.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000256360.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000256443.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000256448.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000256458.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000256481.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000256596.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000256615.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000256802.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000256802.2 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000256894.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000256940.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000256967.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000257095.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000257097.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000257135.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000257151.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000257167.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000257222.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000257261.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000257279.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000257279.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000257298.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000257337.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000257354.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000257496.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000257497.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000257527.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000257557.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000257568.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000257568.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000257568.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000257671.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000257698.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000257808.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000257809.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000257815.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000257910.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000258086.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000258088.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000258102.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000258137.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000258260.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000258303.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000258323.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000258355.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000258400.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000258410.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000258454.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000258458.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000258521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000258537.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000258553.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000258592.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000258604.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000258620.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000258667.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000258673.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000258704.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000258752.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000258760.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000258858.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000258891.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000258902.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000258904.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000258914.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000258919.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000258922.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000258929.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000258935.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000258938.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000258940.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000258942.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000258959.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000258959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000258982.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000258999.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000259070.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000259081.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000259083.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000259103.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000259118.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000259126.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000259163.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000259163.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000259172.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000259201.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000259209.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000259212.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000259230.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000259238.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000259244.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000259245.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000259251.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000259298.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000259319.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000259342.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000259343.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000259345.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000259349.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000259354.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000259372.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000259402.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000259410.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000259418.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000259418.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000259424.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000259439.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000259474.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000259475.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000259521.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000259521.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000259523.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000259561.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000259606.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000259618.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000259623.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000259631.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000259652.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000259652.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000259687.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000259711.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000259712.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000259735.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000259755.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000259768.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000259771.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000259774.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000259774.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000259792.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000259792.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000259804.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000259804.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000259818.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000259820.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000259820.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000259843.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000259865.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000259865.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000259876.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000259877.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000259891.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000259894.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000259899.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000259901.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000259942.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000259954.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000259969.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000259994.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000260022.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000260025.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000260060.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000260077.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000260088.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000260095.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000260132.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000260141.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000260148.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000260167.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000260173.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000260173.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000260177.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000260186.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000260193.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000260196.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000260213.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000260219.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000260260.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000260260.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000260269.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000260269.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000260277.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000260296.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000260331.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000260351.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000260352.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000260360.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000260367.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000260372.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000260378.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000260388.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000260398.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000260400.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000260400.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000260417.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000260423.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000260436.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000260447.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000260448.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000260507.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000260515.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000260526.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000260545.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000260545.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000260552.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000260558.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000260558.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000260572.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000260583.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000260585.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000260588.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000260588.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000260588.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000260589.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000260592.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000260604.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000260618.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000260625.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000260626.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000260641.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000260647.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000260657.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000260664.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000260693.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000260706.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000260742.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000260750.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000260757.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000260766.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000260787.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000260787.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000260790.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000260796.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000260814.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000260830.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000260858.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000260905.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000260905.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000260911.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000260924.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000260924.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000260931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000260936.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000260938.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000260941.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000260948.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000260953.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000260955.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000260971.3 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000260973.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000260977.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000260986.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000261008.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000261024.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000261033.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000261043.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000261068.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000261101.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000261101.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000261101.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000261126.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000261131.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000261140.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000261170.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000261185.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000261187.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000261204.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000261218.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000261238.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000261242.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000261250.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000261280.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000261305.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000261324.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000261341.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000261372.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000261396.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000261428.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000261430.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000261441.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000261462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000261469.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000261471.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000261476.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000261485.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000261488.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000261496.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000261512.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000261519.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000261544.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000261572.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000261574.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000261582.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000261584.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000261597.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000261616.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000261644.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000261645.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000261654.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000261662.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000261693.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000261697.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000261737.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000261754.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000261757.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000261766.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000261770.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000261801.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000261823.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000261824.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000261829.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000261879.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000261889.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000262089.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000262094.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000262094.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000262117.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000262136.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000262155.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000262165.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000262185.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000262222.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000262312.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000262319.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000262343.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000262410.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000262445.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000262514.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000262580.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000262686.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000262692.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000262703.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000262766.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000262777.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000262810.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000262823.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000262837.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000262869.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000262881.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000262921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000262979.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000263011.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000263013.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000263015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000263105.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000263120.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000263293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000263293.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000263331.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000263338.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000263350.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000263388.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000263393.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000263499.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000263618.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000263657.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000263657.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000263674.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000263680.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000263717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000263731.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000263745.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000263859.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000263860.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000263884.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000263893.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000263906.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000263923.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000263924.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000263924.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000263924.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000263938.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000264112.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000264167.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000264188.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000264207.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000264270.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000264272.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000264365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000264456.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000264458.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000264469.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000264513.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000264520.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000264575.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000264589.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000264608.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000264608.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000264829.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000264860.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000264924.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000264932.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000264964.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000264968.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000265008.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000265010.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000265091.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000265094.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000265204.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000265205.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000265334.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000265334.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000265342.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000265342.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000265451.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000265458.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000265458.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000265478.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000265478.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000265479.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000265625.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000265656.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000265688.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000265692.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000265739.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000265766.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000265791.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000265987.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000265992.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000266120.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000266261.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000266283.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000266289.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000266290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000266340.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000266397.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000266397.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000266441.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000266445.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000266644.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000266677.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000266717.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000266801.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000266903.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000266911.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000266921.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000266947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000266965.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000266983.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000266993.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000266993.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000267003.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000267006.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000267006.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000267026.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000267040.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000267040.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000267058.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000267067.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000267095.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000267108.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000267136.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000267138.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000267138.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000267141.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000267143.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000267144.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000267152.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000267169.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000267194.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000267201.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000267202.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000267248.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000267268.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000267273.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000267278.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000267285.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000267289.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000267298.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000267308.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000267342.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000267366.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000267375.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000267449.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000267470.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000267480.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000267481.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000267491.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000267499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000267504.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000267505.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000267547.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000267568.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000267605.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000267638.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000267640.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000267651.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000267651.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000267655.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000267677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000267696.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000267701.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000267702.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000267711.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000267745.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000267751.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000267758.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000267762.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000267765.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000267783.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000267787.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000267787.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000267898.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000267919.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000267939.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000267939.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000267940.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000268056.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000268093.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000268095.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000268199.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000268199.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000268289.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000268364.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000268375.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000268536.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000268543.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000268549.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000268613.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000268649.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000268655.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000268670.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000268670.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000268912.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000268945.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000268945.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000268970.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000269086.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000269086.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000269172.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000269194.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000269194.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000269290.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000269293.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000269352.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000269463.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000269473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000269473.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000269489.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000269534.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000269553.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000269560.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000269653.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000269720.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000269836.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000269843.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000269895.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000269903.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000269918.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000269938.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000269942.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000269944.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000269947.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000269950.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000269951.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000269951.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000269954.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000269961.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000269974.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000269976.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000269979.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000269997.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000270019.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000270031.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000270061.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000270068.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000270069.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000270072.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000270095.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000270100.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000270102.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000270103.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000270109.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000270130.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000270137.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000270140.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000270141.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000270145.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000270154.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000270157.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000270189.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000270237.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000270246.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000270457.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000270557.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000270562.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000270562.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000270571.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000270720.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000270760.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000270761.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000270761.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000270828.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000270876.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000270949.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000270951.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000270951.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000271009.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000271020.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000271109.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000271109.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000271119.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000271127.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000271127.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000271259.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000271265.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000271270.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000271270.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000271327.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000271367.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000271430.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000271555.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000271576.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000271631.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000271716.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000271734.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000271737.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000271738.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000271757.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000271778.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000271782.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000271789.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000271803.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000271821.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000271855.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000271855.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000271856.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000271857.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000271857.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000271869.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000271888.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000271912.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000271916.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000271921.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000271948.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000271966.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000271981.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000271996.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000271998.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000272002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000272003.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000272003.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000272004.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000272009.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000272033.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000272043.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000272053.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000272070.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000272072.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000272077.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000272091.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000272102.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000272103.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000272108.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000272128.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000272142.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000272158.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000272158.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000272172.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000272180.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000272181.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000272181.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000272191.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000272209.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000272217.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000272217.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000272219.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000272219.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000272221.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000272221.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000272226.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000272236.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000272248.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000272250.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000272250.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000272255.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000272273.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000272275.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000272301.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000272341.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000272341.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000272346.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000272365.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000272366.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000272368.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000272369.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000272372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000272373.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000272375.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000272379.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000272379.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000272382.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000272382.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000272384.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000272420.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000272425.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000272426.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000272444.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000272446.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000272446.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000272452.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000272452.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000272452.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000272457.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000272498.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000272516.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000272524.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000272544.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000272556.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000272562.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000272562.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000272564.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000272567.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000272583.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000272650.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000272660.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000272666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000272667.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000272682.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Gemcitabine |
ENSG00000272689.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000272691.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000272709.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000272717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000272719.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000272732.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000272744.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000272746.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000272754.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000272755.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000272764.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000272764.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000272777.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000272782.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000272791.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000272795.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000272795.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000272796.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000272800.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000272808.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000272810.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000272824.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000272849.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000272853.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000272861.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000272862.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000272872.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000272892.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000272894.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000272914.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000272933.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000272942.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000272949.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000272966.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000272970.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000272977.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000272979.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000272983.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000272995.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000273001.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000273008.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000273014.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000273027.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000273027.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000273033.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000273035.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000273035.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000273038.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000273038.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000273065.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000273066.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000273073.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000273073.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000273075.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000273084.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000273091.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000273102.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000273117.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000273142.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000273156.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000273156.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000273162.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000273174.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000273175.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000273243.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000273265.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000273272.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000273281.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000273305.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000273305.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000273307.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Gemcitabine |
ENSG00000273319.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000273338.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Gemcitabine |
ENSG00000273353.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000273355.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000273356.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000273367.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Gemcitabine |
ENSG00000273373.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000273402.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000273402.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000273406.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Gemcitabine |
ENSG00000273428.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000273437.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Gemcitabine |
ENSG00000273447.1 |
Predicted lncRNA |
Sarcoma |
|
| Gemcitabine |
ENSG00000273449.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
ENSG00000273449.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000273451.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Gemcitabine |
ENSG00000273456.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Gemcitabine |
ENSG00000273456.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Gemcitabine |
ENSG00000273472.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000273474.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Gemcitabine |
ENSG00000273487.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Gemcitabine |
ENSG00000273493.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Gemcitabine |
HA-22.1 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
HS-169 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
hsa-let-7c |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-101-3p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-103a-3p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-106a-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-106b-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-107 |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-10b-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-125a-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-125b-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-127-3p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-128-3p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-130b-3p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-136-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-141-3p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-142-3p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-148a-3p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-148b-3p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-15a-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-16-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-17-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-185-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-18a-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-18b-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-19a-3p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-19b-3p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-200c-3p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-203a |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-205-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-20a-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-20b-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-219a-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-22-3p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-25-3p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-26b-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-301b |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-30b-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-30d-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-33a-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-340-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-376a-3p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-376b-3p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-376c-3p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-377-3p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-378a-3p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-379-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-381-3p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-409-3p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-423-3p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-455-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-484 |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-487b |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-493-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-495-3p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-503-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-590-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-652-3p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-7-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-92a-3p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-93-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
hsa-miR-99b-5p |
predicted miRNA |
NCI60 |
|
| Gemcitabine |
let-7 |
Curated miRNA |
KRAS mutation cancer |
|
| Gemcitabine |
let-7a |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
let-7a* |
Curated miRNA |
cholangiocarcinoma |
|
| Gemcitabine |
let-7b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
let-7c |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
let-7d |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
let-7f |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
let-7f-1* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
let-7f-2* |
Curated miRNA |
cholangiocarcinoma |
|
| Gemcitabine |
let-7i |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
let-7i |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
lnc-ASB5-1 |
Curated lncRNA |
pancreatic cancer |
|
| Gemcitabine |
lnc-DRD5-5 |
Curated lncRNA |
pancreatic cancer |
|
| Gemcitabine |
lnc-FAT1-3 |
Curated lncRNA |
pancreatic cancer |
|
| Gemcitabine |
lnc-LMOD1-1 |
Curated lncRNA |
pancreatic cancer |
|
| Gemcitabine |
lnc-MRPL39-3 |
Curated lncRNA |
pancreatic cancer |
|
| Gemcitabine |
Lnc-ZNF532 |
Curated lncRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-100 |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-100 |
Curated miRNA |
pancreatic ductal adenocarcinoma |
|
| Gemcitabine |
miR-101 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-106a |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-106a |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-10a |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-10b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1202 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1226 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1228 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1228* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1234 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1236 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1237 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1246 |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-1246 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1246 |
Curated miRNA |
pancreatic ductal adenocarcinoma |
|
| Gemcitabine |
miR-1247 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1248 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1249 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-125a |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-125a |
Curated miRNA |
Non-small Cell Lung Cancer |
|
| Gemcitabine |
miR-125a |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-125b |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-125b |
Curated miRNA |
breast cancer |
|
| Gemcitabine |
miR-125b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-125b |
Curated miRNA |
pancreatic ductal adenocarcinoma |
|
| Gemcitabine |
miR-126 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1260 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1260b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1261 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1268 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1273c |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1275 |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-1280 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1285 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1287 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1288 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-129* |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-129* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1290 |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-1290 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1301 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1307 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-130a |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-130a |
Curated miRNA |
Non-small Cell Lung Cancer |
|
| Gemcitabine |
miR-130a |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-130b |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-132 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-134 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1343 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-138 |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-138 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-139 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-140 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-141 |
Curated miRNA |
cholangiocarcinoma |
|
| Gemcitabine |
miR-141 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-141* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-142 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-143 |
Curated miRNA |
cholangiocarcinoma |
|
| Gemcitabine |
miR-143 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1468 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1469 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-146a |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-146b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-147b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-148b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-149 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-15 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-151 |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-152 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-155 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-155 |
Curated miRNA |
pancreatic ductal adenocarcinoma |
|
| Gemcitabine |
miR-15a |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-15b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-15b |
Curated miRNA |
pancreatic ductal adenocarcinoma |
|
| Gemcitabine |
miR-16 |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-16 |
Curated miRNA |
malignant pleural mesothelioma |
|
| Gemcitabine |
miR-17 |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-17 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-17* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-17-92 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-181a* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-181a-2 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-181a-2* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-181b |
Curated miRNA |
ovarian cancer |
|
| Gemcitabine |
miR-181b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-181b |
Curated miRNA |
pancreatic ductal adenocarcinoma |
|
| Gemcitabine |
miR-181c |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-181d |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1825 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1826 |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-185 |
Curated miRNA |
ovarian cancer |
|
| Gemcitabine |
miR-187 |
Curated miRNA |
peripheral T-cell lymphoma |
|
| Gemcitabine |
miR-187* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-188 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-18a |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-18a |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-18b |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-18b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1908 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-190b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-191 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1913 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1914* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1915 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-192 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-193a |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-193b* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-194 |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-195 |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-195 |
Curated miRNA |
Non-small Cell Lung Cancer |
|
| Gemcitabine |
miR-196b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1972 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-1976 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-19a |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-19b |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-19b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-19b-1* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-19c |
Curated miRNA |
ovarian cancer |
|
| Gemcitabine |
miR-200 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-200a |
Curated miRNA |
cholangiocarcinoma |
|
| Gemcitabine |
miR-200a |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-200b |
Curated miRNA |
cholangiocarcinoma |
|
| Gemcitabine |
miR-200b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-200b* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-200c |
Curated miRNA |
cholangiocarcinoma |
|
| Gemcitabine |
miR-200c |
Curated miRNA |
Non-small Cell Lung Cancer |
|
| Gemcitabine |
miR-200c |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-200c* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-203 |
Curated miRNA |
Non-small Cell Lung Cancer |
|
| Gemcitabine |
miR-204 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-205 |
Curated miRNA |
cholangiocarcinoma |
|
| Gemcitabine |
miR-205 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-205 |
Curated miRNA |
pancreatic ductal adenocarcinoma |
|
| Gemcitabine |
miR-208a |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-20a |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-20a |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-20b |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-20b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-21 |
Curated miRNA |
adenocarcinoma |
|
| Gemcitabine |
miR-21 |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-21 |
Curated miRNA |
cholangiocarcinoma |
|
| Gemcitabine |
miR-21 |
Curated miRNA |
ovarian cancer |
|
| Gemcitabine |
miR-21 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-21 |
Curated miRNA |
pancreatic ductal adenocarcinoma |
|
| Gemcitabine |
miR-21* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-210 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-211 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-2113 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-214 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-218 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-22 |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-22* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-221 |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-221 |
Curated miRNA |
cholangiocarcinoma |
|
| Gemcitabine |
miR-221* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-222 |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-222 |
Curated miRNA |
cholangiocarcinoma |
|
| Gemcitabine |
miR-222* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-223 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-224 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-224* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-2355 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-24-2* |
Curated miRNA |
Non-small Cell Lung Cancer |
|
| Gemcitabine |
miR-2467 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-25 |
Curated miRNA |
pancreatic ductal adenocarcinoma |
|
| Gemcitabine |
miR-25* |
Curated miRNA |
Non-small Cell Lung Cancer |
|
| Gemcitabine |
miR-25* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-26a-1* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-27a |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-27b |
Curated miRNA |
pancreatic ductal adenocarcinoma |
|
| Gemcitabine |
miR-28 |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-2861 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-29a |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-29a* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-29b |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-29b |
Curated miRNA |
cholangiocarcinoma |
|
| Gemcitabine |
miR-29b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-29b-1* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-29c |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-301a |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-301a |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-301b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3064 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3065 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-30a |
Curated miRNA |
Non-small Cell Lung Cancer |
|
| Gemcitabine |
miR-30a |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-30c-1* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-30c-2* |
Curated miRNA |
Non-small Cell Lung Cancer |
|
| Gemcitabine |
miR-30d |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-30d |
Curated miRNA |
pancreatic ductal adenocarcinoma |
|
| Gemcitabine |
miR-30e |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-31* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3126 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3130 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3131 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3139 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3141 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3147 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3154 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3173 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3177 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3178 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3180 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3184 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3186 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3187 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3188 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3193 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3194 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3195 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-32 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3200 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-320c |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-323 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-324 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-328 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-330 |
Curated miRNA |
cancer |
|
| Gemcitabine |
miR-330 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-338 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-339 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-33a* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-33b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-34 |
Curated miRNA |
gastric cancer |
|
| Gemcitabine |
miR-345 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-346 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-34a |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-34c |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3607 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-361 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3611 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3619 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-362 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3620 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3621 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3647 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-365 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3653 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3665 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3676 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3682 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3687 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-369 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-370 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-371 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-371a |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-371b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-372 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-373 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-373* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-374b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-377 |
Curated miRNA |
cholangiocarcinoma |
|
| Gemcitabine |
miR-378 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-378* |
Curated miRNA |
pancreatic ductal adenocarcinoma |
|
| Gemcitabine |
miR-378a |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-378c |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-378d |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-378e |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-378f |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-378g |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-378i |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3917 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3937 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3940 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-3960 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-421 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-422a |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-423 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-424 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-424* |
Curated miRNA |
pancreatic ductal adenocarcinoma |
|
| Gemcitabine |
miR-425 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-425* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4257 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4258 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4261 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4279 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4284 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4286 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4288 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-429 |
Curated miRNA |
cholangiocarcinoma |
|
| Gemcitabine |
miR-429 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4319 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4324 |
Curated miRNA |
pancreatic ductal adenocarcinoma |
|
| Gemcitabine |
miR-4419b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4428 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4443 |
Curated miRNA |
pancreatic ductal adenocarcinoma |
|
| Gemcitabine |
miR-4447 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4454 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4455 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4463 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4465 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4466 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4467 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4476 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4478 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4483 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4484 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4485 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4485 |
Curated miRNA |
pancreatic ductal adenocarcinoma |
|
| Gemcitabine |
miR-4487 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4488 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4492 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4497 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-449b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-449b* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4508 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-450a |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-450b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4516 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-452 |
Curated miRNA |
cholangiocarcinoma |
|
| Gemcitabine |
miR-452 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4521 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-453 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4530 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4532 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4535 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-454 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-455* |
Curated miRNA |
pancreatic ductal adenocarcinoma |
|
| Gemcitabine |
miR-4638 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4640 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4644 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4646 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4650 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4655 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4665 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4669 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4674 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4675 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4685 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4687 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4689 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4695 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4706 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4707 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4710 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4711 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4713 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4716 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4721 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4722 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4723 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4725 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4731 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4732 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4739 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4745 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4749 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4750 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4758 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4783 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4787 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4791 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-4800 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-483 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-484 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-486 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-487b |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-487b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-491 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-494 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-495 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-497 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-500a |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-500a* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-500b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-503 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-508 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-513a |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-515 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-518b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-518f |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-519d |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-532 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-542 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-542-32 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-542-33a |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-542-33b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-549 |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-557 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-576 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-579 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-584 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-589 |
Curated miRNA |
cholangiocarcinoma |
|
| Gemcitabine |
miR-589 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-590 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-593 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-597 |
Curated miRNA |
cholangiocarcinoma |
|
| Gemcitabine |
miR-602 |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-605 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-6087 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-6134 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-614 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-615 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-622 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-624* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-625* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-629 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-638 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-643 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-647 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-658 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-660 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-663 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-665 |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-665 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-670 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-671 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-675 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-675* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-7 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-708 |
Curated miRNA |
cholangiocarcinoma |
|
| Gemcitabine |
miR-718 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-720 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-762 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-765 |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-766 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-873 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-874 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-885 |
Curated miRNA |
Non-small Cell Lung Cancer |
|
| Gemcitabine |
miR-887 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-9 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-920 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-921 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-92b |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-935 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-939 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-940 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-96 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-98 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-99a |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
miR-99b |
Curated miRNA |
Bladder Carcinoma |
|
| Gemcitabine |
miR-99b |
Curated miRNA |
cholangiocarcinoma |
|
| Gemcitabine |
miR-99b |
Curated miRNA |
pancreatic ductal adenocarcinoma |
|
| Gemcitabine |
miR-99b* |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
OR5H7P |
Curated lncRNA |
pancreatic cancer |
|
| Gemcitabine |
PVT1 |
Curated lncRNA |
pancreatic cancer |
|
| Gemcitabine |
RP11-169O17.1 |
Curated lncRNA |
pancreatic cancer |
|
| Gemcitabine |
RP11-264P13.2 |
Curated lncRNA |
pancreatic cancer |
|
| Gemcitabine |
RP11-58D2.1 |
Curated lncRNA |
pancreatic cancer |
|
| Gemcitabine |
RP13-824C8.2 |
Curated lncRNA |
pancreatic cancer |
|
| Gemcitabine |
solexa-3277-272 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
solexa-578-1915 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
solexa-826-1288 |
Curated miRNA |
pancreatic cancer |
|
| Gemcitabine |
UBA6-AS1 |
Curated lncRNA |
pancreatic cancer |
|
| Gemcitabine |
uc.255 |
Curated lncRNA |
pancreatic cancer |
|